2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing Them
申请人:Allegretti Marcello
公开号:US20110207785A1
公开(公告)日:2011-08-25
The present invention relates to (R,S) 2-aryl-propionic acids and derivatives, their single enantiomer (S) and to pharmaceutical compositions containing them, which are used in the prevention and treatment of tissue damage due to the exacerbated recruitment of polymorphonucleated neutrophils (PIvTN leukocytes) at inflammation sites. The present invention provides compounds for use in the treatment of transient cerebral ischemia, bullous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and damages caused by ischemia and reperfusion. (Formula (I)
2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
申请人:Allegretti Marcello
公开号:US08624036B2
公开(公告)日:2014-01-07
The present invention relates to (R,S) 2-aryl-propionic acids and derivatives, their single enantiomer (S) and to pharmaceutical compositions containing them, which are used in the prevention and treatment of tissue damage due to the exacerbated recruitment of polymorphonucleated neutrophils (PIvTN leukocytes) at inflammation sites. The present invention provides compounds for use in the treatment of transient cerebral ischemia, bullous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and damages caused by ischemia and reperfusion.
STABLE MONOHYDRATE OF DF2755A AND PROCESS FOR ITS PREPARATION
申请人:Dompe' Farmaceutici S.P.A.
公开号:EP4406942A1
公开(公告)日:2024-07-31
The present invention relates to a stable monohydrate of compound DF2755A, to a process for its manufacture, to its pharmaceutical compositions and medical uses.
The monohydrate of compound DF2755A of the present invention is physically, chemically and optically stable, thus particularly advantageous for pharmaceutical applications.